Alpha 2.0
Login Register
» Journals » Integr Cancer Ther

Integrative Cancer Therapies

Integrative Cancer Therapies is a reputable journal dedicated to exploring the integration of conventional and complementary approaches in cancer treatment. It provides a platform for researchers, clinicians, and practitioners to share evidence-based studies, clinical trials, and innovative therapies that aim to enhance patient outcomes and quality of life. This journal serves as a valuable resource for those interested in the multidisciplinary field of integrative cancer care.
Details
Abbr. Integr Cancer Ther
Publisher Sage Publications
Start 2002
End Continuing
Frequency Quarterly
p-ISSN 1534-7354
e-ISSN 1552-695X
Country United States
Language English
Specialties Oncology
Pharmacology
Metrics
h-index / Ranks: 5045 71
SJR / Ranks: 6476 687
CiteScore / Ranks: 4651 5.30
JIF / Ranks: 3624 2.9
Recent Articles
1.
Mechanism Study of Bufalin Reversal of Drug Resistance by Inhibiting Hypoxic Colon Cancer Cell-Induced Polarization of M2 Macrophages
Wang H, Jia L, Yu H, Tang H, Chi H, Zhang W, et al.
Integr Cancer Ther . 2025 Mar; 24:15347354251325806. PMID: 40071641
Chemoresistance is still an important factor affecting the efficacy of treatment in colorectal cancer (CRC) patients. Hypoxia is related to poor prognosis and treatment resistance in cancer. Relevant studies have...
2.
Feasibility of Measuring Context Specific Sedentary Behavior and Pulse Wave Velocity in Endometrial Cancer Survivors
Bates-Fraser L, Diana J, Chauntry A, Bae-Jump V, Meyer M, Moore J, et al.
Integr Cancer Ther . 2025 Mar; 24:15347354251324912. PMID: 40071631
Purpose: Sedentary behavior (SB) contributes to the heightened risk of cardiovascular disease (CVD) in endometrial cancer survivors (ECS). This feasibility study aimed to evaluate key outcomes to assess the practicality...
3.
Induction of Senescence in Lung Cancer Cells by Qidongning Formula via the Transcription Factor EGR1
Zhou D, Yang W, Wang C, Qian C, Xu L, Dong C, et al.
Integr Cancer Ther . 2025 Mar; 24:15347354241307007. PMID: 40029995
The purpose of this study was to investigate the role of the early growth response gene 1 (EGR1) in inducing senescence in lung cancer cells by Qidongning Formula (QDF). Cell-Counting-Kit-8...
4.
Corrigendum to "The Multifaceted Roles of Myrrha in the Treatment of Breast Cancer: Potential Therapeutic Targets and Promises"
Integr Cancer Ther . 2025 Feb; 24:15347354251321239. PMID: 40012252
No abstract available.
5.
A Retrospective Cohort Study on the Preliminary Efficacy of Massage Therapy for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients
Yang M, Shao C, Shao C, Saint K, Gupta M, Caputo R, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251323258. PMID: 39995182
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) worsens the quality of life for people with cancer. Massage therapy involves neuromuscular modulations and can potentially reduce CIPN symptoms. We examined the immediate improvements...
6.
Evaluation of the E-Psycho-Oncological Short-Term Intervention "By Your Side" to Reduce Cancer-Related Distress: A Pilot Study
Strunk S, Graf J, Krakowczyk J, Wieser A, Heinen J, Schug PhD C, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251320047. PMID: 39995154
Objective: A large number of patients with cancer experience distress, but not all of them receive adequate psychological support. The e-psycho-oncological short-term intervention "By your Side" was developed to offer...
7.
The Effect of Rabdosia rubescens on Radiotherapy-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients: A Phase II Clinical Study
Li L, Huang Y, Yin J, Xu P, Lan M, Li C, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251314499. PMID: 39989264
Purpose: Radiotherapy-induced oral mucositis is the most common side effect in nasopharyngeal carcinoma (NPC) patients. We aimed to evaluate the efficacy and safety of Rabdosia rubescens drop pills in NPC...
8.
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial
Cho E, Yi J, Chun J, Jang H, Yoon S, Lee S, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251319339. PMID: 39985390
Background: Non-small cell lung cancer (NSCLC) exhibits low survival rates. Although immune checkpoint inhibitors (ICIs) have become first-line treatment for NSCLC, their limited response to ICI monotherapy has led to...
9.
Effective Herbal Cocktail Strategies and Mechanisms in Cancer Treatment
He T, Zhang Y, Deng D, Yang Z, Zhu Q, Sun Q, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251318759. PMID: 39953838
Systematic treatment and cocktailed drug applications have become a paradigm shift for cancer therapy. This study aims to explore the highly potent herbal cocktail strategies and pharmacological mechanisms, by which...
10.
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
Gu Y, Wang Y, Zhou H, Qi A, Wu G, Li J, et al.
Integr Cancer Ther . 2025 Feb; 24:15347354251314529. PMID: 39915957
Background: With an increasing number of non-small cell lung cancer (NSCLC) patients being offered surgical treatment, postoperative rehabilitation is also being increasingly emphasized. Traditional Chinese medicine (TCM) holds promise for...